主页
市场
图表与思路
Algo
新闻
商店
经纪商
下载
经济日历
交易信号
网页端
热图
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ALXO
#2999
ALX Oncology Holdings Inc. - Common Stock
1.9
2
USD
+1.59%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
+1.59%
每月变动
+20.75%
6个月变化
+44.36%
年变化
+300.00%
前一天收盘价
1.8
9
Open
1.9
3
最低价
1.8
9
High
1.9
3
交易量
366
市场
US Stock Market
医疗保健
ALXO
展开完整图表
完整图表
Financials
概览
声明
统计
每季度
年度
利润表
资产负债表
现金流
值
2020
2021
2022
2023
2024
2025
TTM
经营活动产生的现金
-38.29 M
-68.1 M
-89.22 M
-130.36 M
-121.91 M
-84.14 M
-78.13 M
投资活动产生的现金
610 K
-4.92 M
-235.42 M
44.66 M
86.26 M
82.59 M
-50.09 M
融资活动产生的现金
462.88 M
2.47 M
9.86 M
59.29 M
30.82 M
362 K
139.89 M
自由现金流
-38.29 M
-68.1 M
-89.22 M
-130.36 M
-121.91 M
-84.35 M
-78.33 M
新闻
Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?
ALX Oncology Holdings Inc. (ALXO) Q1 2026 Earnings Call Transcript
ALX Oncology Holdings Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:ALXO) 2026-05-08
bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?
ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA
CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data
IBRX Stock Jumps on Progress in NK Cell Therapy Production
JNJ's Bladder Cancer Therapy Meets Key Goal in Early-Stage Study
RARE's DTX301 Meets First Key Goal in Phase III OTC Deficiency Study
RLMD Stock Surges 42% in a Week: Here's What You Should Know
GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma
EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y